Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank86
3Y CAGR+1.5%
5Y CAGR+14.6%
Year-over-Year Change
Cash generated from core business operations
3Y CAGR
+1.5%/yr
vs +31.3%/yr prior
5Y CAGR
+14.6%/yr
Recent deceleration
Acceleration
-29.8pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $151.99M | -19.7% |
| 2024 | $189.39M | +22.5% |
| 2023 | $154.65M | +6.5% |
| 2022 | $145.27M | +15.6% |
| 2021 | $125.72M | +63.2% |
| 2020 | $77.03M | +9.2% |
| 2019 | $70.52M | +44.3% |
| 2018 | $48.87M | +174.8% |
| 2017 | $17.79M | -46.8% |
| 2016 | $33.45M | - |